Rep. Robert Bresnahan, Jr. Purchases Shares of Agilent Technologies, Inc. (NYSE:A)

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Agilent Technologies, Inc. (NYSE:A). In a filing disclosed on May 31st, the Representative disclosed that they had bought between $1,001 and $15,000 in Agilent Technologies stock on May 15th. The trade occurred in the Representative’s “JP MORGAN BROKERAGE ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Zimmer Biomet (NYSE:ZBH) on 5/15/2025.
• Sold $15,001 – $50,000 in shares of Elevance Health (NYSE:ELV) on 5/15/2025.
• Sold $15,001 – $50,000 in shares of PepsiCo (NASDAQ:PEP) on 5/15/2025.
• Sold $1,001 – $15,000 in shares of WEC Energy Group (NYSE:WEC) on 5/15/2025.
• Purchased $15,001 – $50,000 in shares of Advanced Micro Devices (NASDAQ:AMD) on 5/15/2025.
• Purchased $1,001 – $15,000 in shares of Hershey (NYSE:HSY) on 5/15/2025.
• Purchased $1,001 – $15,000 in shares of Kraft Heinz (NASDAQ:KHC) on 5/15/2025.
• Sold $1,001 – $15,000 in shares of Exxon Mobil (NYSE:XOM) on 5/15/2025.
• Sold $1,001 – $15,000 in shares of Danaher (NYSE:DHR) on 5/15/2025.
• Sold $1,001 – $15,000 in shares of International Flavors & Fragrances (NYSE:IFF) on 5/15/2025.

Agilent Technologies Trading Up 0.9%

Shares of NYSE:A traded up $1.03 during mid-day trading on Tuesday, reaching $112.08. 280,076 shares of the company were exchanged, compared to its average volume of 1,922,501. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The firm’s 50-day simple moving average is $108.27 and its 200 day simple moving average is $126.27. The firm has a market cap of $31.95 billion, a price-to-earnings ratio of 27.67, a P/E/G ratio of 3.40 and a beta of 1.23. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.60.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.63 billion. During the same quarter in the prior year, the firm posted $1.22 earnings per share. Agilent Technologies’s revenue for the quarter was up 6.0% on a year-over-year basis. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be given a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.89%. The ex-dividend date is Tuesday, July 1st. Agilent Technologies’s payout ratio is currently 24.44%.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares of the company’s stock, valued at approximately $2,657,456.28. The trade was a 8.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Daniel K. Podolsky sold 1,819 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares of the company’s stock, valued at $4,161,931.02. This represents a 4.84% decrease in their ownership of the stock. The disclosure for this sale can be found here.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on A shares. UBS Group dropped their target price on Agilent Technologies from $150.00 to $130.00 and set a “neutral” rating for the company in a research note on Thursday, May 29th. TD Cowen lifted their price target on shares of Agilent Technologies to $150.00 and gave the company a “buy” rating in a report on Thursday, May 29th. Leerink Partners increased their price target on Agilent Technologies to $135.00 and gave the stock a “buy” rating in a research note on Friday. Robert W. Baird decreased their price target on shares of Agilent Technologies from $159.00 to $140.00 and set an “outperform” rating on the stock in a research report on Thursday, May 22nd. Finally, JPMorgan Chase & Co. cut their target price on shares of Agilent Technologies from $160.00 to $155.00 and set an “overweight” rating for the company in a research report on Thursday, May 29th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $140.15.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of A. Global X Japan Co. Ltd. grew its position in Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 116 shares during the period. Redwood Park Advisors LLC bought a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $27,000. Lee Danner & Bass Inc. bought a new position in Agilent Technologies in the 4th quarter worth about $29,000. Whipplewood Advisors LLC lifted its position in Agilent Technologies by 286.2% during the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company’s stock valued at $29,000 after purchasing an additional 186 shares during the last quarter. Finally, Sunbelt Securities Inc. grew its position in Agilent Technologies by 640.0% in the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company’s stock worth $30,000 after acquiring an additional 192 shares in the last quarter.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.